Future Healthcare Journal (FHJ) publishes some articles online only. This online content is subject to the same peer review, the same metrics and impact factor as the print journal; it is therefore of equal importance and, crucially, provides us with a wider opportunity to share high-quality content. Articles may be accepted for online-only publication at the editor’s discretion. Online-only articles will be included in the print table of contents and the online issue table of contents of the issue they are assigned to, will be indexed in PubMed and available in PubMed Central, and will receive a DOI.
Types of article we publish
NEW: Rapid reports relating to COVID-19: Both FHJ and Clinical Medicine and are prioritising the rapid peer review and online publication of short reports that share innovative practice helping teams and trusts to meet the demands placed on them by the COVID-19 pandemic. The scopes of the two journals are distinct yet complementary.
For Clinical Medicine, with regard to COVID-19, we aim to publish content themed around:
- clinical impact of the disease, both now and in future phases
- how best to use the hiatus before the next wave of the pandemic
- new ways of working post-COVID-19: data-led pieces on how clinical behaviour/services are being shaped by the pandemic.
FHJ aims to publish content describing COVID-19-driven changes to service that are innovative, likely to be sustainable or inform long-term healthcare delivery.
If you have any queries about which journal your article is best suited to, please contact us on FHJ@rcplondon.ac.uk and we will respond swiftly. The journal editors may redirect articles between the journals if they find it appropriate, keeping the authors informed.
Article format is flexible (although you may like to consider a structure such as 'problem, potential solution, results so far, further evaluation, potential future'). Please select ‘Original article’ when uploading your paper to the submission system and preface your title ‘COVID-19 rapid report’.
Prospective authors are free to share any findings or data on COVID-19 (with colleagues, public health authorities, or on preprint servers) in advance of or during submission and this will not affect publication in the journal.
Original research: Papers reporting and analysing original data derived from systematised research methods with the aim of testing a hypothesis. Articles should not usually exceed 3,000 words (excluding tables, figure legends and references) and 40 references, with figures and tables as required. Please submit under the category of 'Original article'.
Research letters: Shorter pieces of original research, not of sufficient substance to be published as full papers, but which nonetheless have merit and are of interest and use to the readership. Articles should not usually exceed 1,500 words (excluding tables, figure legends and references) and 15 references, with figures and tables as required. Please submit under the category of 'Original article' with the prefix to your title of 'Research letter'.
Reviews: Papers synthesising the results and conclusions of previously published research. Articles should not usually exceed 3,000 words (excluding tables, figure legends and references) and 80 references, with figures and tables as required.
Opinion: Papers in which a topic of interest is discussed from a particular viewpoint, or in which avenues for future research are suggested. Articles should not usually exceed 2,000 words (excluding tables, figure legends and references) and 10 references, with figures and tables as required.
Case studies: Papers describing examples of innovative practice and their outcomes. Articles should not usually exceed 1,500 words (excluding tables, figure legends and references) and 15 references, with figures and tables as required.
Letters to the editor: Readers who disagree with or would like to expand on published articles are encouraged to submit a letter to the editor. Letters should not usually exceed 350 words in length.
If word count is likely to significantly exceed the guidelines given above, please contact the editorial office (FHJ@rcplondon.ac.uk) for advice prior to submission.
How should I prepare my article?
How to structure your article
- Randomised controlled trials: CONSORT
- Observational studies (cohort/case control): STROBE
- Qualitative research: COREQ
- Quality improvement papers: SQUIRE 2.0
- Economic evaluations: CHEERS
- Systematic reviews and meta-analysis: PRISMA
- Introduction (around 200 words): details of the context (eg hospital size and type, type of service, patient demographics) and the specific challenge faced.
- Solution/methodology (around 300 words): a concise summary of the innovation being trialled, including staffing details, funding, partner organisations involved, and study design where relevant.
- Outcome (around 300 words and up to two graphs/tables): where possible, this should include quantitative results.
- Conclusion and next steps (around 300 words): a critical discussion of the success of the trial and next steps (such as further testing or extension).
How to format your article
- Walters L, Greenhill J, Richards J et al. Outcomes of longitudinal integrated clinical placements for students, clinicians and society. Med Educ 2012;46:1028–41.
- Horton R. Second Opinion: Doctors, diseases and decisions in modern medicine. London: Granta Books, 2003.
- Greenaway D (chair). Securing the future of excellent patient care: Final report of the independent review. London: GMC, 2013.
- McDonald J. Shared decision making. In: Wheeler D, Wong H, Shaley T (eds), Future patient care, 2nd edn. London: Springer, 2014:467–81.